Clarity Medical Group Holding Dirección

Dirección controles de criterios 3/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Chris Hui

Chief Executive Officer (CEO)

HK$2.2m

Compensación total

Porcentaje del salario del CEO	96.6%
Permanencia del CEO	1.9yrs
Participación del CEO	n/a
Permanencia media de la dirección	3.5yrs
Promedio de permanencia en la Junta Directiva	5.2yrs

Actualizaciones recientes de la dirección

Recent updates

Investors Could Be Concerned With Clarity Medical Group Holding's (HKG:1406) Returns On Capital

Mar 21

Weak Statutory Earnings May Not Tell The Whole Story For Clarity Medical Group Holding (HKG:1406)

Dec 26

Clarity Medical Group Holding Limited's (HKG:1406) Shares Climb 28% But Its Business Is Yet to Catch Up

Aug 16

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Chris Hui en comparación con los beneficios de Clarity Medical Group Holding?
Fecha	Compensación total	Salario	Ingresos de la empresa
Sep 30 2023	n/a	n/a	-HK$31m
Jun 30 2023	n/a	n/a	-HK$17m
Mar 31 2023	HK$2m	HK$2m	-HK$3m
Dec 31 2022	n/a	n/a	HK$4m
Sep 30 2022	n/a	n/a	HK$11m
Jun 30 2022	n/a	n/a	HK$12m
Mar 31 2022	HK$27k	n/a	HK$13m

Compensación vs. Mercado: La compensación total ($USD277.81K) de Chris está en línea con el promedio de empresas de tamaño similar en el mercado Hong Kong ($USD234.25K).

Compensación vs. Ingresos: La compensación de Chris ha aumentado mientras la empresa no es rentable.

CEO

Chris Hui (55 yo)

1.9yrs

Permanencia

HK$2,177,000

Compensación

Mr. Yung Hui, also known as Chris, serves as External Supervisor at China Bohai Bank Co., Ltd. since December 16, 2019. He is CEO & Executive Director of Clarity Medical Group Holding Limited from June 30,...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Yung Hui	CEO & Executive Director	1.9yrs	HK$2.18m	sin datos
Kin Ho	Financial Controller	9.2yrs	sin datos	sin datos
Tsz Hong Lo	Executive Director	5.2yrs	HK$663.00k	0.35% HK$ 962.0k
Wai Ip Tse	Executive Director	1.9yrs	HK$306.00k	14.82% HK$ 40.7m
Po Yu Chan	Company Secretary	no data	sin datos	sin datos

3.5yrs

Permanencia media

49.5yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de 1406 se considera experimentado (3.5 años antigüedad media).

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Yung Hui	CEO & Executive Director	1.9yrs	HK$2.18m	sin datos
Tsz Hong Lo	Executive Director	5.2yrs	HK$663.00k	0.35% HK$ 962.0k
Wai Ip Tse	Executive Director	1.9yrs	HK$306.00k	14.82% HK$ 40.7m
Wai Hung Ma	Independent Non-Executive Director	3yrs	HK$240.00k	sin datos
Roy Ng	Non-Executive Director	5.2yrs	HK$240.00k	0.85% HK$ 2.3m
Ting Yuk Wu	Non-Executive Chairman	5.2yrs	HK$480.00k	0.71% HK$ 1.9m
Wei Zhao	Non-Executive Director	5.2yrs	HK$240.00k	sin datos
Hankin Li	Independent Non-Executive Director	5.2yrs	HK$240.00k	sin datos

5.2yrs

Permanencia media

56.5yo

Promedio de edad

Junta con experiencia: La junta directiva de 1406 se considera experimentada (5.1 años de antigüedad promedio).

Clarity Medical Group Holding Dirección

Dirección controles de criterios 3/4

Información clave

Actualizaciones recientes de la dirección

Executive Director recently sold HK$5.6m worth of stock

Executive Director recently sold HK$157k worth of stock

Clarity Medical Group Holding Limited Announce Demise of Lau Wan Yee Joseph, Independent Non-Executive Director

Executive Director recently sold HK$482k worth of stock

Executive Director recently sold HK$2.0m worth of stock

Executive Director recently sold HK$2.0m worth of stock

Recent updates

Executive Director recently sold HK$5.6m worth of stock

Executive Director recently sold HK$157k worth of stock

Clarity Medical Group Holding Limited Announce Demise of Lau Wan Yee Joseph, Independent Non-Executive Director

Executive Director recently sold HK$482k worth of stock

Executive Director recently sold HK$2.0m worth of stock

Executive Director recently sold HK$2.0m worth of stock

First half 2024 earnings released: HK$0.038 loss per share (vs HK$0.015 profit in 1H 2023)

New major risk - Revenue size

New minor risk - Share price stability

Clarity Medical Group Holding Limited to Report First Half, 2024 Results on Nov 28, 2023

Clarity Medical Group Holding Limited Provides Earnings Guidance for the Six Months Ended 30 September 2023

Full year 2023 earnings released: HK$0.006 loss per share (vs HK$0.035 profit in FY 2022)

Clarity Medical Group Holding Limited, Annual General Meeting, Sep 20, 2023

Full year 2023 earnings released: HK$0.006 loss per share (vs HK$0.035 profit in FY 2022)

New minor risk - Financial data availability

Clarity Medical Group Holding Limited to Report Fiscal Year 2023 Results on Jun 27, 2023

Clarity Medical Group Holding Limited Provides Earnings Guidance for the Year Ended 31 March 2023

Executive Director recently bought HK$589k worth of stock

Investor sentiment improves as stock rises 16%

Investors Could Be Concerned With Clarity Medical Group Holding's (HKG:1406) Returns On Capital

Non-Executive Director exercised options to buy HK$4.5m worth of stock.

Weak Statutory Earnings May Not Tell The Whole Story For Clarity Medical Group Holding (HKG:1406)

Now 24% undervalued after recent price drop

Less than half of directors are independent

Clarity Medical Group Holding Limited to Report First Half, 2023 Results on Nov 28, 2022

Clarity Medical Group Holding Limited Provides Unaudited Consolidated Earnings Guidance for the Six Months Ended 30 September 2022

Investor sentiment improved over the past week

Executive Director recently bought HK$110k worth of stock

Investor sentiment deteriorated over the past week

Executive Director recently bought HK$59k worth of stock

Executive Director recently bought HK$735k worth of stock

Clarity Medical Group Holding Limited's (HKG:1406) Shares Climb 28% But Its Business Is Yet to Catch Up

Investor sentiment improved over the past week

Full year 2022 earnings released: EPS: HK$0.035 (vs HK$0.095 in FY 2021)

Executive Director recently bought HK$166k worth of stock

Clarity Medical Group Holding Limited Announces Executive Changes

Full year 2022 earnings released: EPS: HK$0.035 (vs HK$0.095 in FY 2021)

Clarity Medical Group Holding Limited, Annual General Meeting, Aug 26, 2022

Clarity Medical Group Holding Limited to Report Fiscal Year 2022 Results on Jun 28, 2022

Clarity Medical Group Holding Limited Provides Consolidated Guidance for the Year Ended March 31, 2022

Executive Director recently sold HK$1.3m worth of stock

Less than half of directors are independent

Executive Director recently sold HK$378k worth of stock

Investor sentiment improved over the past week

Executive Director recently sold HK$58k worth of stock

Investor sentiment deteriorated over the past week

Insider recently bought HK$7.6m worth of stock

Clarity Medical Group Holding Limited has completed an IPO in the amount of HKD 217.6 million.

Less than half of directors are independent

Análisis de compensación del CEO

CEO

Permanencia

Compensación

Equipo directivo

Permanencia media

Promedio de edad

Miembros de la Junta

Permanencia media

Promedio de edad